Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
1.020
-0.030 (-2.86%)
At close: Nov 21, 2024, 4:00 PM
1.021
+0.001 (0.11%)
After-hours: Nov 21, 2024, 5:14 PM EST

Clearside Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-31.88-32.49-32.950.38-18.21-30.77
Upgrade
Depreciation & Amortization
0.170.070.150.180.180.21
Upgrade
Other Amortization
----0.130.07
Upgrade
Loss (Gain) From Sale of Assets
--0.03--0.06
Upgrade
Loss (Gain) From Sale of Investments
------0.12
Upgrade
Stock-Based Compensation
4.374.24.885.053.64.61
Upgrade
Other Operating Activities
8.419.363.28-10.060.16
Upgrade
Change in Accounts Payable
-0.480.610.690.68-0.63-5.58
Upgrade
Change in Unearned Revenue
--0.130.21-5-5
Upgrade
Change in Other Net Operating Assets
0.460.2410.34-11.021.75-0.72
Upgrade
Operating Cash Flow
-18.95-18.14-13.37-10.73-13.12-27.07
Upgrade
Capital Expenditures
-0.65-1.78-0.25--0.06-0.03
Upgrade
Investment in Securities
-9.41----32.95
Upgrade
Investing Cash Flow
-10.07-1.78-0.25--0.0632.93
Upgrade
Long-Term Debt Issued
----0.99-
Upgrade
Long-Term Debt Repaid
-----5.34-5
Upgrade
Net Debt Issued (Repaid)
-----4.35-5
Upgrade
Issuance of Common Stock
15.11.760.723.7812.2213.7
Upgrade
Other Financing Activities
-1-1.3530.64---
Upgrade
Financing Cash Flow
14.10.4131.3323.787.878.7
Upgrade
Net Cash Flow
-14.91-19.517.7213.05-5.3114.55
Upgrade
Free Cash Flow
-19.6-19.91-13.61-10.73-13.18-27.09
Upgrade
Free Cash Flow Margin
-254.47%-242.06%-1025.70%-36.29%-166.90%-1246.80%
Upgrade
Free Cash Flow Per Share
-0.28-0.32-0.23-0.18-0.28-0.71
Upgrade
Cash Interest Paid
----0.520.84
Upgrade
Levered Free Cash Flow
-17.37-17.93-4.49-10.35-6.4-15.99
Upgrade
Unlevered Free Cash Flow
-11.45-12.08-2.4-10.35-6.32-15.41
Upgrade
Change in Net Working Capital
-0.24-0.96-11.7415.2-1.161.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.